At a Glance
Alkeon Capital Management is a prominent crossover investment firm founded in 2007 by Panagiotis Spiliopoulos, who previously worked at Tiger Management. The firm manages both public and private investment strategies, focusing exclusively on technology and healthcare companies with significant growth potential. Alkeon operates from offices in New York, London, and San Francisco, managing over $18 billion in assets across long-only and long/short equity strategies alongside growth equity investments. The firm is known for its analytical, research-driven approach and ability to provide substantial capital to companies transitioning from private to public markets. Alkeon has been an investor in numerous successful technology companies including Snowflake, UiPath, and Toast. The firm typically invests $25-100 million in late-stage private companies and maintains concentrated portfolios of 30-50 positions. Their crossover model allows them to support companies through their entire growth journey, from late-stage private rounds through public market expansion.
“Applies rigorous fundamental research across public and private technology companies to identify compounding growth opportunities.”
Alkeon Capital Management primarily invests at the Series B+ stage. This means they focus on companies that are at various stages of growth.
Alkeon Capital Management is headquartered in New York, NY. Many of their portfolio companies are also based in this region, though they invest across geographies.
Alkeon Capital Management focuses on investments in Enterprise, AI, Consumer, Fintech, SaaS. Their portfolio reflects deep expertise and networks within these sectors.
Alkeon Capital Management's typical investment check size ranges from $25M to $200M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Alkeon Capital Management manages approximately $20B in assets under management (AUM) across their funds.
